UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

Role of Endomyocardial Biopsy in Diagnostics of Myocarditis

Diagnostics (Basel), 2022-08, Vol.12 (9), p.2104

2022

Link zum Volltext

Verfügbarkeit prüfen

Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors

Journal of cardiovascular development and disease, 2023-02, Vol.10 (3), p.104

2023

Link zum Volltext

Verfügbarkeit prüfen

Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?

Medicina (Kaunas, Lithuania), 2019-09, Vol.55 (9), p.586

2019

Link zum Volltext

Verfügbarkeit prüfen

Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)

Europace (London, England), 2021-03, Vol.23 (3), p.362-369

2021

Link zum Volltext

Verfügbarkeit prüfen

Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience

Medicina (Kaunas, Lithuania), 2019-09, Vol.55 (9), p.566

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 252: Resuscitation in Prehospital Stage: Effectiveness and Influencing Factors

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_4)

2020

Link zum Volltext

Verfügbarkeit prüfen

ATRIAL FIBRILLATION IN PATIENTS WITH PHARMACOLOGICALLY CONTROLLED HYPERTENSION – INDIRECT ANTIARRHYTHMIC EFFECTS FOR SINUS RHYTHM MAINTENANCE AFTER ELECTRICAL CARDIOVERSION

Liječnički vjesnik, 2021-05, Vol.142 (Supp 5)

2021

Link zum Volltext

Verfügbarkeit prüfen

The Impact of Pulmonary Vein Anatomy on P-Wave Appearance during Sinus Rhythm: Cardiac Computed Tomography Study

Diagnostics (Basel), 2023-09, Vol.13 (18), p.2911

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients

Medicina (Kaunas, Lithuania), 2022-09, Vol.58 (10), p.1323

2022

Link zum Volltext

Verfügbarkeit prüfen

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

European heart journal, 2022-11, Vol.43 (41), p.4229-4361

2022

Link zum Volltext

Verfügbarkeit prüfen

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

European heart journal, 2021-09, Vol.42 (35), p.3427-3520

2021

Link zum Volltext

Verfügbarkeit prüfen

2018 ESC Guidelines for the diagnosis and management of syncope

European heart journal, 2018-06, Vol.39 (21), p.1883-1948

2018

Link zum Volltext

Verfügbarkeit prüfen

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

European heart journal, 2016-10, Vol.37 (38), p.2893-2962

2016

Link zum Volltext

Verfügbarkeit prüfen

PREVALENCE OF OBSCN TRUNCATING VARIANTS IN LONE ATRIAL FIBRILLATION

Journal of the American College of Cardiology, 2020-03, Vol.75 (11), p.451-451

2020

Link zum Volltext

Verfügbarkeit prüfen

A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients

Medicina (Kaunas, Lithuania), 2021-11, Vol.57 (11), p.1263

2021

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry

American journal of therapeutics, 2024-01, Vol.31 (1), p.e1

2024

Link zum Volltext

Verfügbarkeit prüfen

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

European heart journal cardiovascular imaging, 2022-09, Vol.23 (10), p.e333-e465

2022

Link zum Volltext

Verfügbarkeit prüfen

TWO DOSAGES DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH HIGH RISK OF STROKE AND EMBOLISM UNDERGOING ELECTRICAL CARDIOVERSION WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION

Journal of the American College of Cardiology, 2015, Vol.65 (10), p.A353-A353

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of non-vitamin K antagonist oral anticoagulants one year after electrical cardioversion

Cor et vasa (English ed.), 2021-02, Vol.63 (1), p.6-10

2021

Link zum Volltext

Verfügbarkeit prüfen

SAFETY AND EFFICACY OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION UNDERGOING ELECTRICAL CARDIOVERSION

Journal of the American College of Cardiology, 2014, Vol.63 (12), p.A328-A328

2014

Link zum Volltext

Verfügbarkeit prüfen

Assessment of Cardiac Resynchronisation Therapy Efficacy Determining Factors for Patients with Moderate and Severe Heart Failure in the Population of Latvia in a 12 and 24 Month Study

Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, 2018-12, Vol.72 (6), p.313-321

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

Europace (London, England), 2019-12, Vol.21 (12), p.1802-1808

2019

Link zum Volltext

Verfügbarkeit prüfen

Second European Cardiac Resynchronisation Therapy Survey (Crt Survey Ii): Latvian Data Compared to Europe

Proceedings of the Latvian Academy of Sciences. Section B, Natural Sciences, 2020-12, Vol.74 (6), p.358-365

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(50)

Sprache

Englisch
(50)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Role of Endomyocardial Biopsy in Diagnostics of Myocarditis

Genetic Basis of Early Onset Atrial Fibrillation in Patients without Risk Factors

Is Anticoagulation Necessary for Severely Disabled Cardioembolic Stroke Survivors?

Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)

Lead-Related Infective Endocarditis in Latvia: A Single Centre Experience

Abstract 252: Resuscitation in Prehospital Stage: Effectiveness and Influencing Factors

ATRIAL FIBRILLATION IN PATIENTS WITH PHARMACOLOGICALLY CONTROLLED HYPERTENSION – INDIRECT ANTIARRHYTHMIC EFFECTS FOR SINUS RHYTHM MAINTENANCE AFTER ELECTRICAL CARDIOVERSION

The Impact of Pulmonary Vein Anatomy on P-Wave Appearance during Sinus Rhythm: Cardiac Computed Tomography Study

Impact of Anticoagulants in Reducing Mortality and Disability in Cardioembolic Stroke Patients

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy

2018 ESC Guidelines for the diagnosis and management of syncope

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

PREVALENCE OF OBSCN TRUNCATING VARIANTS IN LONE ATRIAL FIBRILLATION

A Higher Polygenic Risk Score Is Associated with a Higher Recurrence Rate of Atrial Fibrillation in Direct Current Cardioversion-Treated Patients

Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

TWO DOSAGES DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH HIGH RISK OF STROKE AND EMBOLISM UNDERGOING ELECTRICAL CARDIOVERSION WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION

Efficacy and safety of non-vitamin K antagonist oral anticoagulants one year after electrical cardioversion

SAFETY AND EFFICACY OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH PERSISTENT AND LONG-ACTING ATRIAL FIBRILLATION UNDERGOING ELECTRICAL CARDIOVERSION

Assessment of Cardiac Resynchronisation Therapy Efficacy Determining Factors for Patients with Moderate and Severe Heart Failure in the Population of Latvia in a 12 and 24 Month Study

Impact of monitoring on detection of arrhythmia recurrences in the ESC-EHRA EORP atrial fibrillation ablation long-term registry

Second European Cardiac Resynchronisation Therapy Survey (Crt Survey Ii): Latvian Data Compared to Europe

Suchergebnisse filtern